Medical News

RSS

Personality characteristics can play a major role in determining successful medical career

Personality characteristics play a major role in determining who succeeds in medical school, according to new research published in the November issue of the Journal of Applied Psychology.

4 Dec 2009

Scientists discover mechanism by which E6 oncoprotein of high-risk HPV16 promotes carcinogenesis

In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, thus promoting cell growth.

4 Dec 2009

Viral Genetics to develop drug therapies for immune-related disorders and diseases

The University of Colorado and Viral Genetics Inc., recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cancer based on the work of M. Karen Newell, Ph.D., a professor of biology at the University of Colorado at Colorado Springs.

4 Dec 2009

Cancer-free status does not lead to resumption of smoking among former smokers

Assurance of a cancer-free status did not prompt people participating in a long-term computerized tomography (CT) lung-cancer screening program to pick up their cigarettes again, researchers wrote in a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

4 Dec 2009

StemCells welcomes NIH's approval of the first 13 human embryonic stem cell lines for research

StemCells, Inc. announced today that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009.

4 Dec 2009

New evidence of a deep biological link between human music and speech

A pair of studies by Duke University neuroscientists shows powerful new evidence of a deep biological link between human music and speech.

4 Dec 2009

Neurologix completes Phase 2 clinical trial of Parkinson’s study

Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company’s gene transfer approach to the treatment of advanced Parkinson’s disease.

4 Dec 2009

Genzyme announces reopening of enrollment in its Pompe disease ATAP program

Genzyme Corporation announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a program which provides access to treatment for severely affected adults with Pompe disease prior to commercial approval of Lumizyme™ (alglucosidase alfa). Genzyme and the FDA have also agreed on a path toward approval of Lumizyme.

4 Dec 2009

Ambry Genetics and SoftGenetics sign agreement for next-generation sequencing projects at Ambry

Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation sequencing projects performed at Ambry.

4 Dec 2009

New study suggests mental imagery training is sufficient for perceptual learning

Practice makes perfect. But imaginary practice? Elisa Tartaglia of the Laboratory of Psychophysics at Switzerland's Ecole Polytechnique Federale de Lausanne (EPFL) and team show that perceptual learning-learning by repeated exposure to a stimulus-can occur by mental imagery as much as by the real thing. The results, published in Current Biology, suggest that thinking about something over and over again could actually be as good as doing it.

4 Dec 2009

Osseon Therapeutics' Osseoflex and Osseoflex DR systems receive Canadian Medical Device Licenses

Osseon Therapeutics announced today that its Osseoflex (steerable and curvable bone cement delivery needle) and Osseoflex DR (steerable and curvable bone drill) systems for percutaneous vertebral augmentation received Canadian Medical Device Licenses from Health Canada for marketing and clinical use in Canada.

4 Dec 2009

African American and Hispanic adults smoking menthol cigarettes less likely to quit smoking, says study

African American and Hispanic adults who smoke menthol cigarettes may be less likely to quit smoking than those who smoke regular cigarettes, a new study by researchers at the UMDNJ-School of Public Health has found. The report, published in the December issue of Preventive Medicine, is believed to be the first to use national statistics to examine the association between menthol cigarettes and smoking cessation among adults.

4 Dec 2009

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

According to the World Health Organization, the human H1N1/09 Type A influenza ("Swine Flu") has reached a pandemic level. Over 500,000 cases have been confirmed worldwide with at least 6,500 fatalities. Since there is no longer a requirement to test and report individual cases, these numbers undoubtedly understate the real situation.

4 Dec 2009

Kyto advancing with a program for humanization of the mAbTCR23 antibody

Kyto Biopharma Inc., is a biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin B12 platform for the treatment of various forms of cancer.

4 Dec 2009

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help to lessen the final impact of the virus, suggests an epidemiological modelling study

4 Dec 2009

Pfizer announces a $9M cancer research collaboration in British Columbia

Pfizer is entering into a three-year, $9-million research collaboration with the BC Cancer Agency and the Vancouver Prostate Centre, a University of British Columbia (UBC) and Vancouver General Hospital (VGH) Centre of Excellence, to tackle new treatment avenues for breast, ovarian and prostate cancer. This is the single-largest investment by Pfizer into British Columbia's public research sector, and it recognizes the strength and world-class cancer expertise that resides in this province.

4 Dec 2009

Cannabis can reduce spasticity in MS patients

Cannabis can reduce spasticity in multiple sclerosis (MS) patients. A systematic review, published in the open access journal BMC Neurology, found that five out six randomized controlled trials reported a reduction in spasticity and an improvement in mobility.

4 Dec 2009

Study suggests brain can integrate new information without jeopardizing established memories

Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, according to a new study by NYU Langone Medicine Center researchers. The study is published online this week in the journal Nature.

4 Dec 2009

Protein plays a key role in cancer and DNA repair

A protein that plays a key role in copying DNA also plays a vital role in repairing breaks in it, UC Davis scientists have found. The work is helping researchers understand how cancer cells can resist radiation and chemotherapy, as well as how cells become cancerous in the first place.

4 Dec 2009

LCA-MA 2009 Report Card on Lung Cancer released

Today, Lung Cancer Alliance-Massachusetts (LCA-MA) issued its 3rd Annual Report Card on Lung Cancer. The 2009 Report Card is an assessment of progress being made against this lethal disease in the state of Massachusetts.

4 Dec 2009

Medical News

Personality characteristics can play a major role in determining successful medical career

Scientists discover mechanism by which E6 oncoprotein of high-risk HPV16 promotes carcinogenesis

Viral Genetics to develop drug therapies for immune-related disorders and diseases

Cancer-free status does not lead to resumption of smoking among former smokers

StemCells welcomes NIH's approval of the first 13 human embryonic stem cell lines for research

New evidence of a deep biological link between human music and speech

Neurologix completes Phase 2 clinical trial of Parkinson’s study

Genzyme announces reopening of enrollment in its Pompe disease ATAP program

Ambry Genetics and SoftGenetics sign agreement for next-generation sequencing projects at Ambry

New study suggests mental imagery training is sufficient for perceptual learning

Osseon Therapeutics' Osseoflex and Osseoflex DR systems receive Canadian Medical Device Licenses

African American and Hispanic adults smoking menthol cigarettes less likely to quit smoking, says study

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

Kyto advancing with a program for humanization of the mAbTCR23 antibody

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

Pfizer announces a $9M cancer research collaboration in British Columbia

Cannabis can reduce spasticity in MS patients

Study suggests brain can integrate new information without jeopardizing established memories

Protein plays a key role in cancer and DNA repair

LCA-MA 2009 Report Card on Lung Cancer released

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News